Log in  First Connection?

OsteoporosisArchives

Concurrent effects of high-intensity interval training and vitamin D supplementation on bone metabolism among women diagnosed with osteoporosis: a randomized controlled trial
Osteoporosis
 5 min.

 Published on 02/05/2025 |  Original article (Full-text)  | Alghadir Ahmad H. et al. | BMC Musculoskeletal Disorders 2025; 26(1): 381

Osteoporosis is a significant global public health issue, alongside heart disease, cancer, and diabetes, due to its association with increased mortality and morbidity among worldwide [1, 2–3]. Pathologically, osteoporosis is defined as slow bone mass loss and micro-architectural deterioration,...

A reflexive thematic analysis of existential losses in men with osteoporosis: “I’m not the person I was somehow … although I am”
Osteoporosis
 7 min.

 Published on 25/04/2025 |  Original article (Full-text)  | Toye Francine et al. | BMC Musculoskeletal Disorders 2025; 26(1): 294

Osteoporosis is a non-communicable bone disease characterised by loss of bone mass and increased risk of fracture affecting one in three women and one in five men over the age of 50, worldwide [1]. Osteoporosis results in bone fractures at low impact which can cause substantial pain and disability. It...

Dietary riboflavin (vitamin B2) intake and osteoporosis in U.S. female adults: unveiling of association and exploration of potential molecular mechanisms
Osteoporosis
 9 min.

 Published on 18/04/2025 |  Original article (Full-text)  | Yang QianKun et al. | Nutrition Journal 2025; 24(1): 53

Osteoporosis is a systemic skeletal disorder characterized by low bone mass and damage to the bone microstructure, resulting in continuous bone loss and increased bone fragility, as well as susceptibility to fragile fracture [1]. Osteoporosis is called a silent epidemic for it usually goes undiagnosed...

Comparison of different intervention thresholds for the treatment of glucocorticoid-induced osteoporosis: a cross-sectional study
Osteoporosis
 4 min.

 Published on 11/04/2025 |  Original article (Full-text)  | Puksun Kanchalee et al. | BMC Rheumatology 2025; 9(1): 38

Glucocorticoid-induced osteoporosis (GIO) is one of the most common causes of secondary osteoporosis [1]. Glucocorticoids are anti-inflammatory and immunosuppressive drugs used in rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren syndrome, and inflammatory...